Vimarsana
Biggest News Aggregation in the World

Page 12 - Multiple Sclerosis Centers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Centers Today - Breaking & Trending Today

Patient-Reported Outcomes Similar With Extended Natalizumab Dosing Interval - Vimarsana News

Patient-Reported Outcomes Similar With Extended Natalizumab Dosing Interval

NOVA trial looks at 6-week dosing to reduce PML risk

General Neurologists' MS Knowledge Falls Short - Vimarsana News

General Neurologists' MS Knowledge Falls Short

General neurologists fall short in their knowledge of key multiple sclerosis diagnostic criteria standards compared with MS experts, new findings show, which may be detrimental to patient management.

Diroximel Fumarate for Relapsing MS: How Does It Affect Clinical Outcomes? - Vimarsana News

Diroximel Fumarate for Relapsing MS: How Does It Affect Clinical Outcomes?

Diroximel fumarate led to significant improvements in clinical and radiologic outcomes among young adult patients with multiple sclerosis.

Ponesimod Use and Teratogenicity Risk in Women With Multiple Sclerosis - Vimarsana News

Ponesimod Use and Teratogenicity Risk in Women With Multiple Sclerosis

Use of ponesimod in women with multiple sclerosis who are pregnant was not associated with a higher proportion of spontaneous abortions.

COVID-19 Infection, Vaccination May Unmask Underlying Neuroinflammatory Conditions - Vimarsana News

COVID-19 Infection, Vaccination May Unmask Underlying Neuroinflammatory Conditions

Vaccines containing SARS-CoV-2 antigens may lead to enhanced autoimmunity resulting in insidious and extensive inflammation.